Expert Commentary

Webcast: Oral contraceptives and breast cancer: What’s the risk?

OBG Manag. 2016 June;28(6)

By

Ronald T. Burkman, MD

Does the use of oral contraceptives, particularly the presence of estrogen and progesterone, increase the risk of breast cancer? And what about a patient who has a BRCA gene mutation, is her risk altered by her genetic mutation? What the data tell us.

Recommended Reading

The Perfect Storm: Delivery system reform and precision medicine for all

Tamoxifen benefits premenopausal breast cancer patients

‘Extreme’ monitoring fails to boost survival in breast cancer patients

Full course of AI keeps disease at bay longer

High ER expression + high RS spells high risk for late distant recurrence

ASCO issues guidelines for HR+ metastatic breast cancer

Exercise linked to fewer cardiovascular events in nonmetastatic breast cancer patients

Targeting vagal activity could improve breast cancer survival

VIDEO: Doctors should be challenged to extend AIs

Ethnic groups differ in BRCA risk management

All Specialties